Provided by Tiger Trade Technology Pte. Ltd.

PagerDuty, Inc.

15.34
-0.2400-1.54%
Post-market: 15.340.00000.00%19:35 EDT
Volume:1.19M
Turnover:18.38M
Market Cap:1.21B
PE:7.56
High:15.86
Open:15.58
Low:15.24
Close:15.58
52wk High:16.77
52wk Low:5.70
Shares:78.65M
Float Shares:70.64M
Volume Ratio:0.59
T/O Rate:1.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.03
EPS(LYR):1.87
ROE:82.56%
ROA:2.29%
PB:5.20
PE(LYR):8.20

Loading ...

Kelun-Biotech Receives Investigational New Drug Approval from CDE for SKB118, a PD-1 x VEGF Bispecific Antibody

prnewswire
·
May 13

Press Release: PagerDuty to Report First Quarter Fiscal Year 2027 Results on May 28, 2026

Dow Jones
·
May 13

PagerDuty to report first-quarter fiscal 2027 results after market close

Reuters
·
May 13

Analysts Are Bullish on These Technology Stocks: Quantum Computing (QUBT), PagerDuty (PD)

TIPRANKS
·
May 12

Analysts Offer Insights on Technology Companies: PagerDuty (PD) and Infosys (INFY)

TIPRANKS
·
May 12

BRIEF-Pagerduty Appoints John Dilullo As Chief Executive Officer

Reuters
·
May 12

PagerDuty Appoints John DiLullo as CEO

MT Newswires Live
·
May 12

PagerDuty names John DiLullo as new CEO

TIPRANKS
·
May 12

PagerDuty names John DiLullo CEO as Jennifer Tejada becomes executive chair

Reuters
·
May 12

PagerDuty Inc - Expects Q1 Revenue of $118 Mln-$120 Mln and FY2027 Revenue of $488.5 Mln-$496.5 Mln

THOMSON REUTERS
·
May 12

PagerDuty Appoints John Dilullo as Chief Executive Officer

THOMSON REUTERS
·
May 12

Press Release: Gain Therapeutics Reports Financial Results for First Quarter 2026 and Provides Corporate Update

Dow Jones
·
May 11

Climb Bio Reports First Quarter 2026 Financial Results and Provides Business Updates

GlobeNewswire
·
May 07

Aclaris Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate and Clinical Update

GlobeNewswire
·
May 07

Gyre Therapeutics Reports First Quarter 2026 Results and Provides Business Update

GlobeNewswire
·
May 07

Supernus Pharmaceuticals to Participate in the Bank of America 2026 Health Care Conference

GlobeNewswire
·
May 07

PagerDuty announces annual shareholder meeting

Reuters
·
May 05

California Public Utilities Commission Issues Decision in California Water Service’s 2024 General Rate Case, Infrastructure Improvement Plan

GlobeNewswire
·
May 01

Alector to Discontinue Phase 2 PROGRESS-AD Trial of Nivisnebart (AL101/GSK4527226) in Early Alzheimer’s Disease Following Interim Futility Analysis

GlobeNewswire
·
Apr 30

Incyte Exceeds Q1 Expectations Driven by Strong Demand for Core Cancer Therapies

Deep News
·
Apr 28